Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Medical students see AI technologies as a considerable threat to the future of radiology, according to a new study published in the European Journal of Radiology.
Working closely with AI has led researchers from one institution to embrace a familiar piece of technology that may surprise many of their peers: the USB drive.
Gilead Sciences, a Foster City, California-based biopharmaceutical company, is scheduled to present new AI-powered research related to nonalcoholic steatohepatitis (NASH) at The Liver Meeting 2019 in Boston.
Deep learning models can detect signs of Barrett's esophagus (BE) and esophageal cancer in high-resolution microscopy images, according to new research published in JAMA Network Open.
Deep learning techniques have shown potential to change cardiac MRI forever, according to a new analysis published in the American Journal of Roentgenology. However, the authors wrote, it is also important to remember deep learning’s current limitations.
